» Articles » PMID: 31209507

Subjective Responses to Amphetamine in Young Adults with Previous Mood Elevation Experiences

Overview
Specialty Pharmacology
Date 2019 Jun 19
PMID 31209507
Citations 4
Authors
Affiliations
Soon will be listed here.
Abstract

Rationale: One risk factor for alcohol and substance misuse is hypomanic experiences, or periods of mood elevation. Young people who report hypomanic states are more likely to develop bipolar disorder (BP), and BP and other mood disorders increase the risk of addiction. We recently reported that young adults with a history of mood elevation experience less subjective effects from a low dose of alcohol, which may be predictive of future alcohol use. The finding with alcohol raised the question of whether this dampened response to a drug also applies to other drugs, such as amphetamine.

Objective: This study assessed responses of d-amphetamine in healthy young adults with varying experiences of mood elevation, as measured by the Mood Disorders Questionnaire (MDQ).

Methods: Healthy 18-19-year-olds (N = 30) with a range of MDQ scores participated in three 4-h laboratory sessions in which they received placebo, 10 mg, or 20 mg d-amphetamine. They completed mood questionnaires and cardiovascular measures.

Results: Individuals with higher MDQ scores reported less stimulation and euphoria after 10 mg, but not 20 mg, d-amphetamine, than individuals with lower scores. MDQ scores were not related to cardiovascular responses to the drug.

Conclusions: A history of mood elevation experiences or hypomania states is related to dampened response to a low dose of a psychostimulant drug, extending previous findings with dampened response to alcohol. This phenotype for mood disorders of dampened responses to drugs may contribute to risk for subsequent drug use or misuse.

Citing Articles

Impact of childhood adversity on acute subjective effects of stimulant and opioid drugs: Evidence from placebo-controlled studies in healthy volunteers.

Carlyle M, de Wit H, Leknes S J Psychopharmacol. 2024; 38(11):986-997.

PMID: 39118370 PMC: 11528953. DOI: 10.1177/02698811241268892.


Association between psychosis and substance use in Kenya. Findings from the NeuroGAP-Psychosis study.

Nguata M, Orwa J, Kigen G, Kamaru E, Emonyi W, Kariuki S Front Psychiatry. 2024; 15:1301976.

PMID: 38501084 PMC: 10945606. DOI: 10.3389/fpsyt.2024.1301976.


Rewarding Subjective Effects of the NMDAR Antagonist Nitrous Oxide (Laughing Gas) Are Moderated by Impulsivity and Depressive Symptoms in Healthy Volunteers.

Kamboj S, Zhao H, Troebinger L, Piazza G, Cawley E, Hennessy V Int J Neuropsychopharmacol. 2021; 24(7):551-561.

PMID: 33667308 PMC: 8299821. DOI: 10.1093/ijnp/pyab009.


AMPed-up adolescents: The role of age in the abuse of amphetamines and its consequences on cognition and prefrontal cortex development.

Westbrook S, Carrica L, Banks A, Gulley J Pharmacol Biochem Behav. 2020; 198:173016.

PMID: 32828971 PMC: 7554214. DOI: 10.1016/j.pbb.2020.173016.

References
1.
Abi-Dargham A, Kegeles L, Martinez D, Innis R, Laruelle M . Dopamine mediation of positive reinforcing effects of amphetamine in stimulant naïve healthy volunteers: results from a large cohort. Eur Neuropsychopharmacol. 2003; 13(6):459-68. DOI: 10.1016/j.euroneuro.2003.08.007. View

2.
Anand A, Verhoeff P, Seneca N, Zoghbi S, Seibyl J, Charney D . Brain SPECT imaging of amphetamine-induced dopamine release in euthymic bipolar disorder patients. Am J Psychiatry. 2000; 157(7):1108-14. DOI: 10.1176/appi.ajp.157.7.1108. View

3.
Berghorst L, Kumar P, Greve D, Deckersbach T, Ongur D, Dutra S . Stress and reward processing in bipolar disorder: a functional magnetic resonance imaging study. Bipolar Disord. 2016; 18(7):602-611. PMC: 5234857. DOI: 10.1111/bdi.12444. View

4.
Halmoy A, Halleland H, Dramsdahl M, Bergsholm P, Fasmer O, Haavik J . Bipolar symptoms in adult attention-deficit/hyperactivity disorder: a cross-sectional study of 510 clinically diagnosed patients and 417 population-based controls. J Clin Psychiatry. 2010; 71(1):48-57. DOI: 10.4088/JCP.08m04722ora. View

5.
Brown W, Corriveau D, EBERT M . Acute psychologic and neuroendocrine effects of dextroamphetamine and methylphenidate. Psychopharmacology (Berl). 1978; 58(2):189-95. DOI: 10.1007/BF00426906. View